Skip to Content
Merck
  • Microglial A20 Protects the Brain from CD8 T-Cell-Mediated Immunopathology.

Microglial A20 Protects the Brain from CD8 T-Cell-Mediated Immunopathology.

Cell reports (2020-02-06)
Alma Nazlie Mohebiany, Nishada Shakunty Ramphal, Khalad Karram, Giovanni Di Liberto, Tanja Novkovic, Matthias Klein, Federico Marini, Mario Kreutzfeldt, Franziska Härtner, Sonja Maria Lacher, Tobias Bopp, Thomas Mittmann, Doron Merkler, Ari Waisman
ABSTRACT

Tumor-necrosis-factor-alpha-induced protein 3 (TNFAIP3), or A20, is a ubiquitin-modifying protein and negative regulator of canonical nuclear factor κB (NF-κB) signaling. Several single-nucleotide polymorphisms in TNFAIP3 are associated with autoimmune diseases, suggesting a role in tissue inflammation. While the role of A20 in peripheral immune cells has been well investigated, less is known about its role in the central nervous system (CNS). Here, we show that microglial A20 is crucial for maintaining brain homeostasis. Without microglial A20, CD8+ T cells spontaneously infiltrate the CNS and acquire a viral response signature. The combination of infiltrating CD8+ T cells and activated A20-deficient microglia leads to an increase in VGLUT1+ terminals and frequency of spontaneous excitatory currents. Ultimately, A20-deficient microglia upregulate genes associated with the antiviral response and neurodegenerative diseases. Together, our data suggest that microglial A20 acts as a sensor for viral infection and a master regulator of CNS homeostasis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Bromo-2′-deoxyuridine, ≥99% (HPLC)
Sigma-Aldrich
Papain from papaya latex, lyophilized powder, ≥10 units/mg protein
Sigma-Aldrich
Tamoxifen, ≥99%
Sigma-Aldrich
Anti-NeuN Antibody, clone A60, clone A60, Chemicon®, from mouse
Roche
DNase I, grade II, from bovine pancreas